Quest Diagnostics Long Term Debt 2010-2024 | DGX

Quest Diagnostics long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  • Quest Diagnostics long term debt for the quarter ending March 31, 2024 was $3.804B, a 4.3% decline year-over-year.
  • Quest Diagnostics long term debt for 2023 was $4.41B, a 10.86% increase from 2022.
  • Quest Diagnostics long term debt for 2022 was $3.978B, a 0.8% decline from 2021.
  • Quest Diagnostics long term debt for 2021 was $4.01B, a 0.07% decline from 2020.
Quest Diagnostics Annual Long Term Debt
(Millions of US $)
2023 $4,410
2022 $3,978
2021 $4,010
2020 $4,013
2019 $3,966
2018 $3,429
2017 $3,748
2016 $3,728
2015 $3,492
2014 $3,224
2013 $3,120
2012 $3,354
2011 $3,371
2010 $2,641
2009 $2,937
Quest Diagnostics Quarterly Long Term Debt
(Millions of US $)
2024-03-31 $3,804
2023-12-31 $4,410
2023-09-30 $3,946
2023-06-30 $3,777
2023-03-31 $3,975
2022-12-31 $3,978
2022-09-30 $3,980
2022-06-30 $3,983
2022-03-31 $3,985
2021-12-31 $4,010
2021-09-30 $4,006
2021-06-30 $4,008
2021-03-31 $4,010
2020-12-31 $4,013
2020-09-30 $4,018
2020-06-30 $4,020
2020-03-31 $4,033
2019-12-31 $3,966
2019-09-30 $3,188
2019-06-30 $3,169
2019-03-31 $3,131
2018-12-31 $3,429
2018-09-30 $3,394
2018-06-30 $3,408
2018-03-31 $3,718
2017-12-31 $3,748
2017-09-30 $3,759
2017-06-30 $3,732
2017-03-31 $3,725
2016-12-31 $3,728
2016-09-30 $3,815
2016-06-30 $3,835
2016-03-31 $3,740
2015-12-31 $3,492
2015-09-30 $3,571
2015-06-30 $3,568
2015-03-31 $3,688
2014-12-31 $3,224
2014-09-30 $3,732
2014-06-30 $3,738
2014-03-31 $3,724
2013-12-31 $3,120
2013-09-30 $3,122
2013-06-30 $3,122
2013-03-31 $3,147
2012-12-31 $3,354
2012-09-30 $3,376
2012-06-30 $3,378
2012-03-31 $3,365
2011-12-31 $3,371
2011-09-30 $3,368
2011-06-30 $3,333
2011-03-31 $3,595
2010-12-31 $2,641
2010-09-30 $2,836
2010-06-30 $2,974
2010-03-31 $2,945
2009-12-31 $2,937
2009-09-30 $2,878
2009-06-30 $2,878
2009-03-31 $3,077
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $15.557B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.097B 10.34
DaVita (DVA) United States $11.598B 14.41
Encompass Health (EHC) United States $8.513B 21.79
Chemed (CHE) United States $8.407B 26.06
Elanco Animal Health (ELAN) United States $8.149B 21.14
Option Care Health (OPCH) United States $4.971B 18.82
RadNet (RDNT) United States $4.259B 88.69
Amedisys (AMED) United States $3.144B 22.27
LifeStance Health (LFST) United States $2.217B 0.00
Astrana Health (ASTH) United States $2.112B 28.55
Addus HomeCare (ADUS) United States $1.785B 25.54
U.S Physical Therapy (USPH) United States $1.515B 40.54
Pennant (PNTG) United States $0.681B 35.97
Aveanna Healthcare Holdings (AVAH) United States $0.521B 0.00
Atai Life Sciences (ATAI) Germany $0.273B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.027B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.016B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00